Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry.

Kalogeras K, Jabbour RJ, Ruparelia N, Watson S, Kabir T, Naganuma T, Vavuranakis M, Nakamura S, Malik IS, Mikhail G, Dalby M, Panoulas V.

J Thromb Thrombolysis. 2019 Oct 11. doi: 10.1007/s11239-019-01968-w. [Epub ahead of print]

PMID:
31605280
2.

What are the remaining lessons to be learnt from 1st-generation bioresorbable scaffolds?

Tanaka A, Jabbour RJ, Colombo A.

Int J Cardiol. 2019 Oct 15;293:103-104. doi: 10.1016/j.ijcard.2019.07.037. Epub 2019 Jul 22. No abstract available.

PMID:
31358305
3.

The changing landscape of interventional cardiology.

Jabbour RJ, Latib A.

Aging (Albany NY). 2019 May 29;11(10):2914-2915. doi: 10.18632/aging.102005. No abstract available.

4.

Biomimetic electromechanical stimulation to maintain adult myocardial slices in vitro.

Watson SA, Duff J, Bardi I, Zabielska M, Atanur SS, Jabbour RJ, Simon A, Tomas A, Smolenski RT, Harding SE, Perbellini F, Terracciano CM.

Nat Commun. 2019 May 15;10(1):2168. doi: 10.1038/s41467-019-10175-3.

5.

Loss of Cajal bodies in motor neurons from patients with novel mutations in VRK1.

El-Bazzal L, Rihan K, Bernard-Marissal N, Castro C, Chouery-Khoury E, Desvignes JP, Atkinson A, Bertaux K, Koussa S, Lévy N, Bartoli M, Mégarbané A, Jabbour R, Delague V.

Hum Mol Genet. 2019 Jul 15;28(14):2378-2394. doi: 10.1093/hmg/ddz060.

PMID:
31090908
6.

Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.

Tanaka A, Jabbour RJ, Testa L, Agnifili M, Ettori F, Fiorina C, Adamo M, Bruschi G, Giannini C, Petronio AS, Barbanti M, Tamburino C, De Felice F, Reimers B, Poli A, Colombo A, Latib A.

Cardiovasc Revasc Med. 2019 May;20(5):371-375. doi: 10.1016/j.carrev.2019.01.026. Epub 2019 Feb 14.

PMID:
30857975
7.

Valve durability - is this the Achilles' heel of TAVI?

Jabbour RJ, Mikhail GW.

EuroIntervention. 2019 Feb 8;14(15):e1544-e1547. doi: 10.4244/EIJV14I15A263. No abstract available.

8.

Delayed Coronary Occlusion After Transcatheter Aortic Valve Implantation: Implications for New Transcatheter Heart Valve Design and Patient Management.

Jabbour RJ, Tanaka A, Colombo A, Latib A.

Interv Cardiol. 2018 Sep;13(3):137-139. doi: 10.15420/icr.2018.24.2. Review.

9.

Causes of death in older patients with cancer: Experience of a tertiary care center in Lebanon.

Assi T, Bakouny Z, Labaki C, El Rassy E, Khazzaka A, Jabbour R, Haddad FG, Tohme A, El Karak F, Ghosn M, Kattan J.

J Geriatr Oncol. 2019 Mar;10(2):365-367. doi: 10.1016/j.jgo.2018.10.017. Epub 2018 Oct 31. No abstract available.

PMID:
30391115
10.

The "new" syndrome of delayed coronary obstruction after transcatheter aortic valve replacement.

Jabbour RJ, Latib A.

Cardiovasc Revasc Med. 2019 Jan;20(1):81-83. doi: 10.1016/j.carrev.2018.10.004. Epub 2018 Oct 4. No abstract available.

PMID:
30314834
11.

Emergency Medical Services Utilization and Outcomes of Patients with ST-Elevation Myocardial Infarction in Lebanon.

Rebeiz A, Sasso R, Bachir R, Mneimneh Z, Jabbour R, El Sayed M.

J Emerg Med. 2018 Dec;55(6):827-835. doi: 10.1016/j.jemermed.2018.09.016. Epub 2018 Oct 6.

PMID:
30301584
12.

Bioresorbable vascular scaffold implantation for severely calcified lesions after excimer laser lesion preparation.

Mitomo S, Jabbour RJ, Latib A, Colombo A.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1283-1288. doi: 10.1002/ccd.27704. Epub 2018 Sep 30.

PMID:
30269391
13.

Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement.

Mangieri A, Lanzillo G, Bertoldi L, Jabbour RJ, Regazzoli D, Ancona MB, Tanaka A, Mitomo S, Garducci S, Montalto C, Pagnesi M, Giannini F, Giglio M, Montorfano M, Chieffo A, Rodès-Cabau J, Monaco F, Paglino G, Della Bella P, Colombo A, Latib A.

JACC Cardiovasc Interv. 2018 Aug 13;11(15):1519-1526. doi: 10.1016/j.jcin.2018.06.014.

14.

Percutaneous left atrial appendage occlusion with the Amulet device: The impact of device disc position upon periprocedural and long-term outcomes.

Oraii Yazdani K, Mitomo S, Ruparelia N, Candilio L, Giannini F, Jabbour RJ, Regazzoli D, Mazzone P, Stella S, Sora N, Montorfano M, Colombo A, Latib A.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):120-127. doi: 10.1002/ccd.27727. Epub 2018 Aug 5.

PMID:
30079565
15.

A Patient with Schizencephaly and Agenesis of Corpus Callosum with No Neurological Deficits.

Ghosn Y, Kamareddine MH, Adem C, Jabbour R.

J Neurosci Rural Pract. 2018 Jul-Sep;9(3):404-405. doi: 10.4103/jnrp.jnrp_564_17. No abstract available.

16.

Variation in vessel healing response after implantation of two different poly-L-lactic acid bioresorbable scaffolds: insights from optical coherence tomography.

Mitomo S, Latib A, Jabbour RJ, Demir OM, Granada JF, Colombo A.

EuroIntervention. 2018 Dec 20;14(12):e1304-e1305. doi: 10.4244/EIJ-D-18-00456. No abstract available.

17.

Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85].

Kawamoto H, Chieffo A, D'Ascenzo F, Jabbour RJ, Naganuma T, Cerrato E, Ugo F, Pavani M, Varbella F, Boccuzzi G, Pennone M, Garbo R, Conrotto F, Biondi-Zoccai G, D'Amico M, Moretti C, Escaned J, Gaita F, Nakamura S, Colombo A.

Int J Cardiol. 2018 Jul 15;263:188. doi: 10.1016/j.ijcard.2018.03.090. No abstract available.

PMID:
29685694
18.

Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry.

Mitomo S, Jabbour RJ, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Giannini F, Carlino M, Montorfano M, Chieffo A, Latib A, Colombo A.

Int J Cardiol. 2018 Jul 15;263:17-23. doi: 10.1016/j.ijcard.2018.04.050. Epub 2018 Apr 13.

PMID:
29685691
19.

Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.

Giannini F, Baldetti L, Ponticelli F, Ruparelia N, Mitomo S, Latib A, Montorfano M, Jabbour RJ, Aurelio A, Ferri L, Mangieri A, Regazzoli D, Ancona M, Pagnesi M, Faccini A, Chieffo A, Azzalini L, Carlino M, Colombo A.

JACC Cardiovasc Interv. 2018 Apr 23;11(8):784-792. doi: 10.1016/j.jcin.2018.01.251.

20.

Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.

Jabbour RJ, Tanaka A, Finkelstein A, Mack M, Tamburino C, Van Mieghem N, de Backer O, Testa L, Gatto P, Purita P, Rahhab Z, Veulemans V, Stundl A, Barbanti M, Nerla R, Sinning JM, Dvir D, Tarantini G, Szerlip M, Scholtz W, Scholtz S, Tchetche D, Castriota F, Butter C, Søndergaard L, Abdel-Wahab M, Sievert H, Alfieri O, Webb J, Rodés-Cabau J, Colombo A, Latib A.

J Am Coll Cardiol. 2018 Apr 10;71(14):1513-1524. doi: 10.1016/j.jacc.2018.01.066.

21.

Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease: A Systematic Review and Network Meta-Analysis of Prospective Trials.

Bakouny Z, Yared F, El Rassy E, Jabbour R, Hallit R, Khoury N, Honein K, Bou Jaoude J.

J Clin Gastroenterol. 2019 Jul;53(6):409-417. doi: 10.1097/MCG.0000000000001006.

PMID:
29517709
22.

Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.

Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A.

Int J Cardiol. 2018 Mar 1;254:53-58. doi: 10.1016/j.ijcard.2017.10.066. Epub 2018 Jan 28.

PMID:
29407132
23.

Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis.

Ahmad Y, Demir O, Rajkumar C, Howard JP, Shun-Shin M, Cook C, Petraco R, Jabbour R, Arnold A, Frame A, Sutaria N, Ariff B, Kanaganayagam G, Francis D, Mayet J, Mikhail G, Malik I, Sen S.

Open Heart. 2018 Jan 26;5(1):e000748. doi: 10.1136/openhrt-2017-000748. eCollection 2018.

24.

Severe Mitral Stenosis and Persistent Left Appendage Thrombosis: When an Old Percutaneous Solution Meets New Percutaneous Strategies.

Mangieri A, Montorfano M, Stella S, Regazzoli D, Ancona MB, Jabbour RJ, Mitomo S, Seresini G, Monaco F, Lanzillo G, Pagnesi M, Colombo A, Latib A.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):e11-e13. doi: 10.1016/j.jcin.2017.10.030. Epub 2017 Dec 27. No abstract available.

25.

Definite stent thrombosis after drug-eluting stent implantation in coronary bifurcation lesions: A meta-analysis of 3,107 patients from 14 randomized trials.

Zhou Y, Chen S, Huang L, Hildick-Smith D, Ferenc M, Jabbour RJ, Azzalini L, Colombo A, Chieffo A, Zhao X.

Catheter Cardiovasc Interv. 2018 Oct 1;92(4):680-691. doi: 10.1002/ccd.27443. Epub 2017 Dec 7.

PMID:
29214736
26.

Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation.

Ancona MB, Giannini F, Mangieri A, Regazzoli D, Jabbour RJ, Tanaka A, Testa L, Romano V, Longoni M, Giglio M, Besana F, Cacucci M, Agricola E, Chieffo A, Alfieri O, Montorfano M, Colombo A, Latib A.

Am J Cardiol. 2017 Dec 15;120(12):2233-2240. doi: 10.1016/j.amjcard.2017.09.006. Epub 2017 Sep 18.

PMID:
29106835
27.

A "Jail Escape Technique" (JET) for distal side branch wiring during provisional stenting: Feasibility and first-in-man study.

Xiao H, Chen S, Wang G, Du R, Song Y, Jin J, Huang L, Jabbour R, Azzalini L, Zhao X.

J Interv Cardiol. 2017 Dec;30(6):527-534. doi: 10.1111/joic.12456. Epub 2017 Nov 1.

PMID:
29094411
28.

Day case TAVI: is this a reality?

Jabbour RJ, Frame A, Sen S, Malik IS, Mikhail GW.

EuroIntervention. 2017 Oct 20;13(8):907-909. doi: 10.4244/EIJV13I8A135. No abstract available.

29.

Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study.

Kawamoto H, Chieffo A, D'Ascenzo F, Jabbour RJ, Naganuma T, Cerrato E, Ugo F, Pavani M, Varbella F, Boccuzzi G, Pennone M, Garbo R, Conrotto F, Biondi-Zoccai G, D'Amico M, Moretti C, Escaned J, Gaita F, Nakamura S, Colombo A.

Int J Cardiol. 2018 Jan 1;250:80-85. doi: 10.1016/j.ijcard.2017.09.207. Epub 2017 Oct 4. Erratum in: Int J Cardiol. 2018 Apr 20;:.

PMID:
28992999
30.

Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction.

Chow A, Stuckey DJ, Kidher E, Rocco M, Jabbour RJ, Mansfield CA, Darzi A, Harding SE, Stevens MM, Athanasiou T.

Stem Cell Reports. 2017 Nov 14;9(5):1415-1422. doi: 10.1016/j.stemcr.2017.09.003. Epub 2017 Oct 5.

31.

A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.

Giannini F, Latib A, Montorfano M, Ruparelia N, Romano V, Longoni M, Ferri L, Jabbour R, Mangieri A, Regazzoli D, Ancona M, Buzzatti N, Azzalini L, Tanaka A, Agricola E, Chieffo A, Alfieri O, Colombo A.

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):966-974. doi: 10.1002/ccd.27319. Epub 2017 Sep 20.

PMID:
28941127
32.

Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.

Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino M, Montorfano M, Colombo A.

Int J Cardiol. 2017 Nov 1;246:26-31. doi: 10.1016/j.ijcard.2017.03.123.

PMID:
28867010
33.

Impact of target vessel on long-term cardiac mortality after successful chronic total occlusion percutaneous coronary intervention: Insights from a Japanese multicenter registry.

Mitomo S, Naganuma T, Jabbour RJ, Sato K, Takebayashi H, Kobayashi T, Obata JE, Sakamoto K, Tsujita K, Kugiyama K, Ogawa H, Nakamura S.

Int J Cardiol. 2017 Oct 15;245:77-82. doi: 10.1016/j.ijcard.2017.07.098. Epub 2017 Aug 4.

PMID:
28789842
34.

Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort.

Mitomo S, Latib A, Tanaka A, Jabbour RJ, Regazzoli D, Leone PP, Giannini F, Chieffo A, Carlino M, Montorfano M, Colombo A.

JACC Cardiovasc Interv. 2017 Jul 24;10(14):1471-1472. doi: 10.1016/j.jcin.2017.05.040. No abstract available.

35.

Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options.

Mangieri A, Montalto C, Pagnesi M, Jabbour RJ, Rodés-Cabau J, Moat N, Colombo A, Latib A.

Circ Cardiovasc Interv. 2017 Jul;10(7). pii: e005043. doi: 10.1161/CIRCINTERVENTIONS.117.005043. Review.

PMID:
28698289
36.

A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization.

Giannini F, Ruparelia N, Del Furia F, Romano V, Ancona M, Mangieri A, Regazzoli D, Latib A, Godino C, Ancona F, Candilio L, Jabbour R, Colombo A, Montorfano M.

Can J Cardiol. 2017 Jul;33(7):951.e1-951.e3. doi: 10.1016/j.cjca.2017.03.027. Epub 2017 Apr 8.

PMID:
28668149
37.

Advances in percutaneous interventional therapies: the tricuspid valve.

Jabbour RJ, Giannini F, Tanaka A, Mangieri A, Mikhail GW, Latib A, Colombo A.

Future Cardiol. 2017 May;13(3):239-245. doi: 10.2217/fca-2016-0072. Epub 2017 May 31. Review.

PMID:
28560929
38.

An Unusual Presentation of Acute Fibrinous and Organizing Pneumonia.

Jabbour R, Kumar H, Alvi S, Nannaka VB, Niazi M, Patel M, Chilimuri S.

Am J Case Rep. 2017 May 15;18:532-536.

39.

Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with bioresorbable scaffolds.

Mangieri A, Jabbour RJ, Tanaka A, Aurelio A, Colombo A, Latib A.

J Cardiovasc Med (Hagerstown). 2016 Dec;17 Suppl 2:e149-e150. doi: 10.2459/JCM.0000000000000397.

PMID:
28472818
40.

Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation.

Tanaka A, Jabbour RJ, Giannini F, Latib A, Colombo A.

J Invasive Cardiol. 2017 May;29(5):E63.

41.

Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation.

Spartera M, Jabbour RJ, Chiarito M, De Bonis M, Pappalardo F.

Cardiovasc Revasc Med. 2017 Sep;18(6):447-449. doi: 10.1016/j.carrev.2017.04.001. Epub 2017 Apr 8.

PMID:
28432006
42.

Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution.

Tanaka A, Latib A, Jabbour RJ, Mitomo S, Regazzoli D, Leone PP, Chieffo A, Carlino M, Montorfano M, Colombo A.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):745-746. doi: 10.1016/j.jcin.2017.01.037. No abstract available.

43.

Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions.

Jabbour RJ, Tanaka A, Capranzano P, Cortese B, Lesiak M, Testa L, Gatto P, Suarez de Lezo J, Mattesini A, Geraci S, Ielasi A, Diletti R, Capodanno D, Buccheri D, Iwanczyk S, Bedogni F, Tchetche D, Di Mario C, Caramanno G, Van Mieghem NM, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):743-745. doi: 10.1016/j.jcin.2017.01.038. No abstract available.

44.

First-in-man Percutaneous LAA Closure With an Amplatzer Amulet and TriGuard Embolic Protection Device in a Patient With LAA Thrombus.

Del Furia F, Ancona MB, Giannini F, Jabbour RJ, Regazzoli D, Mangieri A, Latib A, Colombo A, Montorfano M.

J Invasive Cardiol. 2017 Apr;29(4):E51-E52.

45.

Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning.

Giannini F, Montorfano M, Jabbour RJ, Latib A, Ruparelia N, Azzalini L, Magni V, Romano V, De Bonis M, Pappalardo F, Colombo A.

Cardiovasc Revasc Med. 2017 Sep;18(6S1):54-55. doi: 10.1016/j.carrev.2017.03.012. Epub 2017 Mar 15.

PMID:
28342841
46.

The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation.

Giannini F, Latib A, Jabbour RJ, Slavich M, Benincasa S, Chieffo A, Montorfano M, Stella S, Buzzatti N, Alfieri O, Colombo A.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5):349-355. doi: 10.1016/j.carrev.2017.02.011. Epub 2017 Feb 20.

PMID:
28342840
47.

Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease.

Spartera M, Godino C, Baldissera E, Campochiaro C, La Spina K, Aiello P, Salerno A, Cera M, Magni V, Jabbour RJ, Dagna L, Tresoldi M, Cappelletti A, Alfieri O, Colombo A, Sabbadini MG, Margonato A.

Am J Cardiovasc Dis. 2017 Feb 15;7(1):9-18. eCollection 2017.

48.

Out-of-hospital cardiac arrest: Concise review of strategies to improve outcome.

Jabbour RJ, Sen S, Mikhail GW, Malik IS.

Cardiovasc Revasc Med. 2017 Sep;18(6):450-455. doi: 10.1016/j.carrev.2017.03.011. Epub 2017 Mar 15. Review.

PMID:
28336077
49.

Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions.

Tanaka A, Jabbour RJ, Mitomo S, Latib A, Colombo A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):539-547. doi: 10.1016/j.jcin.2016.12.285. Review.

50.

A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions.

Jabbour RJ, Ielasi A, Tanaka A, Leoncini M, Cortese B, Grigis G, Mitomo S, Regazzoli D, Di Palma G, Rapetto C, Tespili M, Colombo A, Latib A.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5S1):S4-S9. doi: 10.1016/j.carrev.2017.03.007. Epub 2017 Mar 8.

PMID:
28314675

Supplemental Content

Loading ...
Support Center